Fly News Breaks for March 13, 2019
Mar 13, 2019 | 07:48 EDT
As previously reported, Bernstein analyst Lance Wilkes started coverage of CVS Health with an Outperform rating and $76 price target. The analyst believes the current stock price does not reflect Aetna's solid MCO business and the long-term value of a care delivery strategy at retail. Further, he thinks the current valuation already reflects potential shock to PBM margins and future deterioration in the retail business.
News For CVS;AET From the Last 2 Days
There are no results for your query CVS;AET